| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58a073155b21492a12567512af263187 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate |
1980-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ce6329b5a94c8992c781491238afec |
| publicationDate |
1981-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0029151-A2 |
| titleOfInvention |
6-Alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates |
| abstract |
Novel 6a-fluoro-9a-chloro-, 6a-fluoro-9a-chloro-16a-methyl- and 6α-fluoro-9α-chloro-16β-methyl-prednisolone 17,21-diesters, and a method for their preparation, are described. The novel products are particularly valuable as anti-inflammatory agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0170500-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0170500-A2 |
| priorityDate |
1979-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |